Clinical Trials

Neuroendocrine Tumor

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 2 of 2 Clinical Trials Related to Neuroendocrine Tumor

Clinical Research Trial

A021804 Neuroendocrine Cancer

A021804 A Prospective, Multi-Institutional Phase Ii Trial Evaluating Temozolomide Vs. Temozolomide And Olaparib For Advanced Pheochromocytoma And Paraganglioma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A021603 Neuroendocrine Tumors

A021602 – Randomized, double-blinded phase III study of cabozantinib versus placebo in patients with advanced neuroendocrine tumors after progression on everolimus (CABINET)

Doctor(s) Running This Study
Maged F. Khalil, MD